Investigation Overview
December 5, 2016 (Shareholders Foundation) - An investigation on behalf of investors in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) was announced over potential breaches of fiduciary duties by certain directors at Amicus Therapeutics. The investigation by a law firm concerns whether certain Amicus Therapeutics directors breached their fiduciary duties and caused damage to the c...
You must register (for free) or login to view the entire investigation.